GefitinibDevelopment of resistance in lung adenocarcinoma transforming to small cell lung cancer: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2017年 / 1659卷 / 1期
关键词：
D O I：
10.1007/s40278-017-32793-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：135 / 135
相关论文
共 50 条
  • [41] Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib
    Manca, Paolo
    Russano, Marco
    Pantano, Francesco
    Tonini, Giuseppe
    Santini, Daniele
    ONCOTARGET, 2017, 8 (35) : 59986 - 59990
  • [42] Transformation of Lung Squamous Cell Carcinoma to Small Cell Lung Cancer After Immunotherapy Resistance: A Case Report
    Wang, Diming
    Ye, Wei
    Chen, Dongmei
    Shi, Qingming
    Ma, Dongchun
    CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 803 - 808
  • [43] Transformation of lung adenocarcinoma to small cell lung cancer following osimertinib treatment: a case report and literature review
    Kuang, Linwu
    Wang, Peng
    Zhou, Lin
    Li, Yangkai
    ANTI-CANCER DRUGS, 2025, 36 (03) : 253 - 259
  • [44] An EGFR-mutant lung adenocarcinoma that transformed into small- cell lung cancer. A case report
    Chowaniecova, Gabriela
    Berzinec, Peter
    Kosturiakova, Gabriela
    Plank, Lukas
    Farkasova, Anna
    Sekeresova, Monika
    Juskanic, Dominik
    Ondrus, Dalibor
    BIOMEDICAL PAPERS-OLOMOUC, 2022, 166 (04): : 451 - 454
  • [45] CrizotinibAcquired resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2014, 1500 (1) : 15 - 15
  • [46] CrizotinibDevelopment of resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2017, 1633 (1) : 231 - 231
  • [47] AlectinibDevelopment of resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2017, 1682 (1) : 24 - 24
  • [48] CrizotinibDevelopment of resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2019, 1754 (1) : 120 - 120
  • [49] AfatinibAfatinib resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2017, 1656 (1) : 21 - 21
  • [50] AntineoplasticsLack of efficacy, drug resistance and small cell lung cancer: case report
    Reactions Weekly, 2022, 1894 (1) : 41 - 41
12345